Cargando…

Navigating patient journey in early diagnosis of lung cancer in India

Lung cancer (LC) is one of the leading causes of cancer deaths worldwide. In India, the incidence of LC is increasing rapidly, and a majority of the patients are diagnosed at advanced stages of the disease when treatment is less likely to be effective. Recent therapeutic developments have significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Biswas, Bivas, Talwar, Deepak, Meshram, Priti, Julka, Pramod K., Mehta, Anurag, Somashekhar, SP, Chilukuri, Srinivas, Bansal, Abhishek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894269/
https://www.ncbi.nlm.nih.gov/pubmed/36695259
http://dx.doi.org/10.4103/lungindia.lungindia_144_22
_version_ 1784881708294733824
author Biswas, Bivas
Talwar, Deepak
Meshram, Priti
Julka, Pramod K.
Mehta, Anurag
Somashekhar, SP
Chilukuri, Srinivas
Bansal, Abhishek
author_facet Biswas, Bivas
Talwar, Deepak
Meshram, Priti
Julka, Pramod K.
Mehta, Anurag
Somashekhar, SP
Chilukuri, Srinivas
Bansal, Abhishek
author_sort Biswas, Bivas
collection PubMed
description Lung cancer (LC) is one of the leading causes of cancer deaths worldwide. In India, the incidence of LC is increasing rapidly, and a majority of the patients are diagnosed at advanced stages of the disease when treatment is less likely to be effective. Recent therapeutic developments have significantly improved survival outcomes in patients with LC. Prompt specialist referral remains critical for early diagnosis for improved patient survival. In the Indian scenario, distinguishing LC from benign and endemic medical conditions such as tuberculosis can pose a challenge. Hence, awareness regarding the red flags—signs and symptoms that warrant further investigations and referral—is vital. This review is an effort toward encouraging general physicians to maintain a high index of clinical suspicion for those at risk of developing LC and assisting them in refering patients with concerning symptoms to specialists or multidisciplinary teams as early as possible.
format Online
Article
Text
id pubmed-9894269
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-98942692023-02-03 Navigating patient journey in early diagnosis of lung cancer in India Biswas, Bivas Talwar, Deepak Meshram, Priti Julka, Pramod K. Mehta, Anurag Somashekhar, SP Chilukuri, Srinivas Bansal, Abhishek Lung India Review Lung cancer (LC) is one of the leading causes of cancer deaths worldwide. In India, the incidence of LC is increasing rapidly, and a majority of the patients are diagnosed at advanced stages of the disease when treatment is less likely to be effective. Recent therapeutic developments have significantly improved survival outcomes in patients with LC. Prompt specialist referral remains critical for early diagnosis for improved patient survival. In the Indian scenario, distinguishing LC from benign and endemic medical conditions such as tuberculosis can pose a challenge. Hence, awareness regarding the red flags—signs and symptoms that warrant further investigations and referral—is vital. This review is an effort toward encouraging general physicians to maintain a high index of clinical suspicion for those at risk of developing LC and assisting them in refering patients with concerning symptoms to specialists or multidisciplinary teams as early as possible. Wolters Kluwer - Medknow 2023 2022-12-29 /pmc/articles/PMC9894269/ /pubmed/36695259 http://dx.doi.org/10.4103/lungindia.lungindia_144_22 Text en Copyright: © 2022 Indian Chest Society https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review
Biswas, Bivas
Talwar, Deepak
Meshram, Priti
Julka, Pramod K.
Mehta, Anurag
Somashekhar, SP
Chilukuri, Srinivas
Bansal, Abhishek
Navigating patient journey in early diagnosis of lung cancer in India
title Navigating patient journey in early diagnosis of lung cancer in India
title_full Navigating patient journey in early diagnosis of lung cancer in India
title_fullStr Navigating patient journey in early diagnosis of lung cancer in India
title_full_unstemmed Navigating patient journey in early diagnosis of lung cancer in India
title_short Navigating patient journey in early diagnosis of lung cancer in India
title_sort navigating patient journey in early diagnosis of lung cancer in india
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894269/
https://www.ncbi.nlm.nih.gov/pubmed/36695259
http://dx.doi.org/10.4103/lungindia.lungindia_144_22
work_keys_str_mv AT biswasbivas navigatingpatientjourneyinearlydiagnosisoflungcancerinindia
AT talwardeepak navigatingpatientjourneyinearlydiagnosisoflungcancerinindia
AT meshrampriti navigatingpatientjourneyinearlydiagnosisoflungcancerinindia
AT julkapramodk navigatingpatientjourneyinearlydiagnosisoflungcancerinindia
AT mehtaanurag navigatingpatientjourneyinearlydiagnosisoflungcancerinindia
AT somashekharsp navigatingpatientjourneyinearlydiagnosisoflungcancerinindia
AT chilukurisrinivas navigatingpatientjourneyinearlydiagnosisoflungcancerinindia
AT bansalabhishek navigatingpatientjourneyinearlydiagnosisoflungcancerinindia